These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4208713)

  • 1. Differential analysis of cyclocytidine, 1-beta-D-arabinofuranosylcytosine, and 1-beta-D-arabinofuranosyluracil by ultraviolet spectophotometry.
    Furner RL; Gaston RW; Strobel JD; el-Dareer S; Mellett LB
    J Natl Cancer Inst; 1974 May; 52(5):1521-8. PubMed ID: 4208713
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution and excretion of cyclocytidine in monkeys, dogs, and rats.
    Hirayama H; Sugihara T; Hamada F; Kanai T; Hikita J
    Gan; 1974 Apr; 65(2):153-61. PubMed ID: 4209835
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.
    Ho DH; Frei E
    Clin Pharmacol Ther; 1971; 12(6):944-54. PubMed ID: 5289712
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation and properties of O'-methyl and O'-ethyl derivatives of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil.
    Darzynkiewicz E; Shugar D
    Acta Biochim Pol; 1974; 21(3):305-22. PubMed ID: 4440349
    [No Abstract]   [Full Text] [Related]  

  • 5. A radioimmunoassay method for 1-beta-D-arabinofuranosyluracil using antibodies directed against 1-beta-D-arabinofuranosylcytosine.
    Okabayashi T; Mihara S; Moffatt JG
    Cancer Res; 1977 Feb; 37(2):625-8. PubMed ID: 12864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radioimmunoassay for 1-beta-D-arabinofuranosylcytosine.
    Okabayashi T; Mihara S; Repke DB; Moffatt JG
    Cancer Res; 1977 Feb; 37(2):619-24. PubMed ID: 832282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radioimmunoassay for 1-beta-D-arabinofuranosyluracil with reference to cross-reactivity of 1-beta-D-arabinofuranosylcytosine with an antibody.
    Okabayashi T; Mihara S; Repke DB; Moffatt JG
    Cancer Res; 1977 Sep; 37(9):3132-5. PubMed ID: 18280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatographic analysis (TLC) of uracil arabinoside, cytosine arabinoside, uracil and cytosine in human plasma.
    Paw B; Misztal G
    Acta Pol Pharm; 1995; 52(6):455-7. PubMed ID: 8960263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous analysis of 1-beta-D-arabinofuranosylcytosine, 1-beta-D-arabinofuranosyluracil and sodium salicylate in biological samples by high-performance liquid chromatography.
    Liversidge GG; Nishihata T; Higuchi T; Shaffer R; Cortese M
    J Chromatogr; 1983 Sep; 276(2):375-83. PubMed ID: 6630386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic analysis of cytosine arabinoside and metabolites in biological samples.
    Pallavicini MG; Mazrimas JA
    J Chromatogr; 1980 Oct; 183(4):449-58. PubMed ID: 7430297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microbiological assay for cyclocytidine--disposition studies in mice.
    Neil GL; Kuentzel SL; Berger AE
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):561-72. PubMed ID: 4633769
    [No Abstract]   [Full Text] [Related]  

  • 12. 5'-O-methyl derivatives of 1- -D-arabinofuranosylcytosine and 1- -D-arabinofuranosyluracil.
    Giziewicz J; Kuśmierek JT; Shugar D
    J Med Chem; 1972 Aug; 15(8):839-40. PubMed ID: 5044298
    [No Abstract]   [Full Text] [Related]  

  • 13. Ion-pair liquid chromatography of cytarabine and uracil-arabinoside in human plasma.
    Burk M; Volmer M; Fartash K; Schneider W
    Arzneimittelforschung; 1995 May; 45(5):616-9. PubMed ID: 7612064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of cyclocytidine and arabinosylcytosine disposition in rats.
    Novotný L; Farghali H; Janků I; Beránek J
    Neoplasma; 1988; 35(6):707-14. PubMed ID: 2464769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies in vitro on some precursors of 1- -D-arabinosylcytosine.
    Hayashikawa RH; Nagyvary J
    Biochem Pharmacol; 1973 Mar; 22(5):609-22. PubMed ID: 4692170
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of [3H]cytosine arabinoside and its products in mice, dogs, and monkeys and effect of tetrahydrouridine.
    Dareer SM; Mulligan LT; White V; Tillery K; Mellett LB; Hill DL
    Cancer Treat Rep; 1977; 61(3):395-407. PubMed ID: 406044
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous determination of 1-β-d-Arabinofuranosylcytosine and two metabolites, 1-β-d-Arabinofuranosyluracil and 1-β-d-Arabinofuranosylcytosine triphosphate in leukemic cell by HPLC-MS/MS and the application to cell pharmacokinetics.
    Liang D; Wang W; Jiang X; Yin S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():14-19. PubMed ID: 24880220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of formation of blood-borne uridine and cytidine in dogs.
    Tseng J; Barelkovski J; Gurpide E
    Am J Physiol; 1971 Sep; 221(3):869-78. PubMed ID: 5570345
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of effect of 1-beta-D-arabinofuranosylcytosine, its 5'-palmitoyl ester, 1-beta-D-arabinofuranosyluracil, and tritiated thymidine on the viability of cultured leukemia L1210 cells.
    Wilkoff LJ; Dulmadge EA; Lloyd HH
    J Natl Cancer Inst; 1972 Mar; 48(3):685-95. PubMed ID: 5058968
    [No Abstract]   [Full Text] [Related]  

  • 20. High-performance liquid chromatographic assay for cytosine arabinoside and uracil arabinoside in cerebrospinal fluid and plasma.
    Riccardi A; Servidei T; Lasorella A; Riccardi R
    J Chromatogr; 1989 Dec; 497():302-7. PubMed ID: 2625467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.